RE: KeeperMilestones over the next 2 years will greatly advance the development of both STS and Exherin. In 2 years we will have Phase III data on STS. Probably be in Phase III tests of exherin with a clear indication of efficacy.
It is all about progressing the value of the drugs. The more developed they are the more they are worth in a collaboration deal. The more we get for a collaboration deal the more the stock is worth.
Couple that with the fact that biotech runs in 5 year cycles and we are about 5 years away from the last run on biotech. I think 2 years we will have the market on our side. Drugs that fill a huge need and large pharma scrabbling to replace their drugs comming off patent. A company like ours will be worth far more than the 90 million in market cap that it is valued at today.
I beleive in the drug. Worse case scenerio the patents and work todate is worth at least the $90 million. I really don't see very much down side from here. Up side is very big.
If you are trading it is probably not a stock to get in right now. But if you are looking for a huge return long term. Now is a pretty good time.
Hope this elaboration clarifies my position